| MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |
| IFNA2 |
P01563
|
interferon alpha 2
|
|
|
0.442 |
0.885 |
| PDR |
|
pigment disorder, reticulate
|
|
|
0.592 |
0.692 |
| AMD1P2 |
|
adenosylmethionine decarboxylase 1 pseudogene 2
|
|
|
0.608 |
0.538 |
| CST12P |
|
cystatin 12, pseudogene
|
|
|
0.641 |
0.615 |
| MYP2 |
|
myopia 2 (high grade, autosomal dominant)
|
|
|
0.659 |
0.308 |
| FCMTE2 |
|
familial cortical myoclonic tremor with epilepsy 2
|
|
|
0.743 |
0.231 |
| FCMTE1 |
|
familial cortical myoclonic tremor with epilepsy 1
|
|
|
0.769 |
0.231 |
| PLA2G7 |
Q13093
|
phospholipase A2 group VII
|
Enzyme
|
5.3E-22 |
0.537 |
0.769 |
| MALRD1 |
Q5VYJ5
|
MAM and LDL receptor class A domain containing 1
|
|
9.4E-21 |
0.821 |
0.346 |
| WDHD1 |
O75717
|
WD repeat and HMG-box DNA binding protein 1
|
Nucleic acid binding
|
4.4E-18 |
0.529 |
0.846 |
| OPTN |
Q96CV9
|
optineurin
|
|
5.9E-18 |
0.548 |
0.808 |
| MMP9 |
P14780
|
matrix metallopeptidase 9
|
Enzyme
|
1.9E-17 |
0.305 |
0.923 |
| TDRD9 |
Q8NDG6
|
tudor domain containing 9
|
Enzyme
|
7.3E-15 |
0.711 |
0.385 |
| KLKB1 |
P03952
|
kallikrein B1
|
Enzyme
|
6.3E-13 |
0.604 |
0.692 |
| LAMC2 |
Q13753
|
laminin subunit gamma 2
|
Enzyme modulator
|
2.9E-12 |
0.389 |
0.923 |
| ANGPTL4 |
Q9BY76
|
angiopoietin like 4
|
Signaling
|
2.3E-11 |
0.498 |
0.731 |
| P2RX7 |
Q99572
|
purinergic receptor P2X 7
|
Ion channel
|
3.3E-11 |
0.450 |
0.808 |
| COL18A1 |
P39060
|
collagen type XVIII alpha 1 chain
|
|
1.7E-10 |
0.449 |
0.808 |
| KNG1 |
P01042
|
kininogen 1
|
Enzyme modulator
|
3.2E-10 |
0.481 |
0.885 |
| CCR5 |
P51681
|
C-C motif chemokine receptor 5 (gene/pseudogene)
|
G-protein coupled receptor
|
4.3E-10 |
0.398 |
0.885 |
| CIAO3 |
Q9H6Q4
|
cytosolic iron-sulfur assembly component 3
|
Enzyme
|
1.9E-09 |
0.700 |
0.462 |
| HYLS1 |
Q96M11
|
HYLS1 centriolar and ciliogenesis associated
|
|
2.3E-09 |
0.572 |
0.692 |
| IL3 |
P08700
|
interleukin 3
|
|
2.6E-09 |
0.489 |
0.731 |
| VPS51 |
Q9UID3
|
VPS51 subunit of GARP complex
|
|
1.1E-08 |
0.452 |
0.846 |